Improvement in Health-Related Quality of Life Following Treatment with Betibeglogene Autotemcel in Patients with Transfusion-Dependent ß-Thalassemia Enrolled in Phase 3 Studies

被引：3

作者：

Kwiatkowski, Janet L. ^{[1
,2
]}

Locatelli, Franco ^{[3
]}

Walters, Mark C. ^{[4
]}

Porter, John B. ^{[5
]}

Hongeng, Suradej ^{[6
]}

Yannaki, Evangelia ^{[7
]}

Kulozik, Andreas E. ^{[8
,9
]}

Sauer, Martin G. ^{[10
]}

Thrasher, Adrian J. ^{[11
]}

Thuret, Isabelle ^{[12
]}

Lal, Ashutosh ^{[4
]}

Guo, Ruiting ^{[13
]}

Colvin, Richard A. ^{[13
]}

Gruppioni, Katiana ^{[13
]}

Thompson, Alexis A. ^{[14
,15
]}

机构：

[1] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA USA

[2] Childrens Hosp Philadephia, Div Hematol, Philadelphia, PA USA

[3] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol Oncol, Cell & Gene Therapy, Rome, Italy

[4] UCSF Benioff Childrens Hosp Oakland, Div Hematol, Oakland, CA USA

[5] Univ Coll London Hosp, Dept Haematol, London, England

[6] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand

[7] G Papanikolaou Hosp, Hematol HCT Unit, Gene & Cell Therapy Ctr, Thessaloniki, Greece

[8] Heidelberg Univ, Mol Med Partnership Unit MMPU, European Mol Biol Lab EMBL, Heidelberg, Germany

[9] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany

[10] Hannover Med Sch, Dept Hematol & Oncol, Hannover, Germany

[11] UCL Great Ormond St Inst Child Hlth, London, England

[12] Hop La Timone, Pediat Hematol, Marseille, France

[13] Bluebird Bio Inc, Cambridge, MA USA

[14] Ann Robert H Lurie Childrens Hosp Chicago, Hematol Sect, Chicago, IL USA

[15] Northwestern Univ, Dept Pediat Hematol Oncol & Stem Cell Transplant, Feinberg Sch Med, Chicago, IL USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-150392

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3085

引用

页数：6

共 50 条

[21] Favorable Outcomes in Pediatric Patients in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia
Thompson, Alexis A.
Kwiatkowski, Janet L.
Porter, John B.
Hongeng, Suradej
Yannaki, Evangelia
Kulozik, Andreas E.
Sauer, Martin G.
Thrasher, Adrian J.
Thuret, Isabelle
Lal, Ashutosh
Guo, Ruiting
Liu, Weijian
Colvin, Richard A.
Walters, Mark C.
Locatelli, Franco
BLOOD, 2020, 136
[22] Olfactory dysfunction and quality of life in patients with transfusion-dependent thalassemia
Yilmaz, Yasin
Karakas, Zeynep
Uzun, Busra
Sen, Comert
Comoglu, Senol
Orhan, Kadir Serkan
Aydogdu, Selime
Karagenc, Ayse Ozkan
Tugcu, Deniz
Karaman, Serap
Wylie, Crystal
Doty, Richard L.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (09) : 3417 - 3421
[23] Olfactory dysfunction and quality of life in patients with transfusion-dependent thalassemia
Yasin Yilmaz
Zeynep Karakas
Busra Uzun
Comert Sen
Senol Comoglu
Kadir Serkan Orhan
Selime Aydogdu
Ayse Ozkan Karagenc
Deniz Tugcu
Serap Karaman
Crystal Wylie
Richard L. Doty
European Archives of Oto-Rhino-Laryngology, 2017, 274 : 3417 - 3421
[24] Betibeglogene Autotemcel (Beti-Cel; Lentiglobin for B-Thalassemia) Gene Therapy Treatment of A Greek Patient with Transfusion-Dependent B-Thalassemia (TDT)
Constantinou, Varnavas
Papayanni, Penelope
Mallouri, Despoina
Batsis, Ioannis
Sotiropoulos, Damianos
Bouinta, Asimina
Papadopoulou, Despoina
Papadimitriou, Vasiliki
Kammenou, Maria
Liu, Weijian
Colvin, Richard
Sakellari, Ioanna
Anagnostopoulos, Achilles
Yannaki, Evangelia
BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 215 - 216
[25] Clinical outcomes following autologous hematopoietic stem cell transplantation with betibeglogene autotemcel (beti-cel, LentiGlobin for β-thalassemia) gene therapy in the phase 3 Northstar-2 and Northstar-3 studies for transfusion-dependent β-thalassemia (TDT)
Kulozik, A. E.
Locatelli, F.
Kunz, J.
Kwiatkowski, J. L.
Thompson, A. A.
Yannaki, E.
Sauer, M. G.
Schambach, A.
Schmidt, M.
Porter, J. B.
Thuret, I.
Hongeng, S.
Lal, A.
Thrasher, A. J.
Tao, G.
Liu, W.
Colvin, R. A.
Walters, M. C.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 33 - 33
[26] BETIBEGLOGENE AUTOTEMCEL (BETI-CEL) GENE THERAPY FOR THE TREATMENT OF TRANSFUSION-DEPENDENT β-THALASSEMIA (TDT): UPDATED LONG-TERM EFFICACY AND SAFETY RESULTS
Locatelli, F.
Yannaki, E.
Kwiatkowski, J. L.
Walters, M. C.
Porter, J. B.
Hongeng, S.
Kulozik, A. E.
Sauer, M. G.
Thrasher, A. J.
Thuret, I.
Lal, A.
Cavazzana, M.
Du, Lin
Colvin, R. A.
Rasko, J. E. J.
Algeri, M.
Thompson, A. A.
HAEMATOLOGICA, 2021, 106 (10) : 7 - 8
[27] Response of Patients with Transfusion-Dependent β-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers
Walters, Mark C.
Chui, David H. K.
Farrell, John J.
Lal, Ashutosh
Locatelli, Franco
Kwiatkowski, Janet L.
Porter, John B.
Sauer, Martin G.
Thuret, Isabelle
Hongeng, Suradej
Kulozik, Andreas E.
Thrasher, Adrian J.
Yannaki, Evangelia
Yang, Julia
Whitney, Dustin
Petrusich, Alexandria
Colvin, Richard A.
Thompson, Alexis A.
BLOOD, 2020, 136
[28] A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
Cappellini, M. D.
Viprakasit, V.
Taher, A. T.
Georgiev, P.
Kuo, K. H. M.
Coates, T.
Voskaridou, E.
Liew, H. -K.
Pazgal-Kobrowski, I.
Forni, G. L.
Perrotta, S.
Khelif, A.
Lal, A.
Kattamis, A.
Vlachaki, E.
Origa, R.
Aydinok, Y.
Bejaoui, M.
Ho, P. J.
Chew, L. -P.
Bee, P. -C.
Lim, S. -M.
Lu, M. -Y.
Tantiworawit, A.
Ganeva, P.
Gercheva, L.
Shah, F.
Neufeld, E. J.
Thompson, A.
Laadem, A.
Shetty, J. K.
Zou, J.
Zhang, J.
Miteva, D.
Zinger, T.
Linde, P. G.
Sherman, M. L.
Hermine, O.
Porter, J.
Piga, A.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (13): : 1219 - 1231
[29] Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT
Cheuk, D. K. L.
Mok, A. S. P.
Lee, A. C. W.
Chiang, A. K. S.
Ha, S. Y.
Lau, Y. L.
Chan, G. C. F.
BONE MARROW TRANSPLANTATION, 2008, 42 (05) : 319 - 327
[30] Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT
D K L Cheuk
A S P Mok
A C W Lee
A K S Chiang
S Y Ha
Y L Lau
G C F Chan
Bone Marrow Transplantation, 2008, 42 : 319 - 327

← 1 2 3 4 5 →